Local Failure After Episcleral Brachytherapy for Posterior Uveal Melanoma: Patterns, Risk Factors, and Management

2017 ◽  
Vol 181 ◽  
pp. 178-179
Author(s):  
Paul T. Finger ◽  
Wolfgang A.G. Sauerwein
2017 ◽  
Vol 177 ◽  
pp. 9-16 ◽  
Author(s):  
Claudine Bellerive ◽  
Hassan A. Aziz ◽  
James Bena ◽  
Allan Wilkinson ◽  
John H. Suh ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1700
Author(s):  
Melissa Chalada ◽  
Charmaine A. Ramlogan-Steel ◽  
Bijay P. Dhungel ◽  
Christopher J. Layton ◽  
Jason C. Steel

Uveal melanoma (UM) is currently classified by the World Health Organisation as a melanoma caused by risk factors other than cumulative solar damage. However, factors relating to ultraviolet radiation (UVR) susceptibility such as light-coloured skin and eyes, propensity to burn, and proximity to the equator, frequently correlate with higher risk of UM. These risk factors echo those of the far more common cutaneous melanoma (CM), which is widely accepted to be caused by excessive UVR exposure, suggesting a role of UVR in the development and progression of a proportion of UM. Indeed, this could mean that countries, such as Australia, with high UVR exposure and the highest incidences of CM would represent a similarly high incidence of UM if UVR exposure is truly involved. Most cases of UM lack the typical genetic mutations that are related to UVR damage, although recent evidence in a small minority of cases has shown otherwise. This review therefore reassesses statistical, environmental, anatomical, and physiological evidence for and against the role of UVR in the aetiology of UM.


1982 ◽  
Vol 13 (12) ◽  
pp. 1147-1148 ◽  
Author(s):  
Willem A. Manschot ◽  
Henny A. Van Peperzeel

2020 ◽  
Vol 50 (3) ◽  
pp. 156-162
Author(s):  
Gökçen Özcan ◽  
Ahmet Kaan Gündüz ◽  
İbadulla Mirzayev ◽  
Kaan Oysul ◽  
Hasan Uysal

2016 ◽  
Vol 254 (9) ◽  
pp. 1787-1792 ◽  
Author(s):  
Ira Seibel ◽  
Dino Cordini ◽  
Annette Hager ◽  
Johanna Tillner ◽  
Aline I. Riechardt ◽  
...  

2009 ◽  
Vol 101 (2) ◽  
pp. 120-123 ◽  
Author(s):  
Andreas Stang ◽  
Andrea Schmidt-Pokrzywniak ◽  
Timothy L. Lash ◽  
Peter Karl Lommatzsch ◽  
Gerhard Taubert ◽  
...  

Author(s):  
Leyla Jabbarli ◽  
Maja Guberina ◽  
Eva Biewald ◽  
Dirk Flühs ◽  
Nika Guberina ◽  
...  
Keyword(s):  

2021 ◽  
pp. 112067212199513
Author(s):  
Sven Holger Baum ◽  
Henrike Westekemper ◽  
Nikolaos Emmanouel Bechrakis ◽  
Christopher Mohr

Purpose: This study aims to analyse disease-free survival, overall survival and risk factors after orbital exenteration in patients with conjunctival and uveal melanoma. Methods: Patients who underwent orbital exenteration due to conjunctival and uveal melanoma were included in this retrospective study (March 2000 to March 2018). Results: A total of 76 patients were enrolled in this study: 60 patients had a conjunctival melanoma and 16 had a uveal melanoma. In conjunctival melanoma, the mean age was 68.4 years. The overall survival rate was 82% after 1 year and 52% after 5 years. Univariate analysis of overall survival found that the following parameters were predictive of a worse prognosis: gender, extent of the primary tumour, lymph node metastases, distant metastases, adjuvant chemotherapy or radiotherapy and relapse. In multivariate analysis, relapse and adjuvant radiotherapy appeared to contribute to a significantly worse prognosis. In uveal melanoma, the mean age was 63.6 years. Eleven patients died during follow-up (mean follow up 30.7 months). The overall survival and disease-free survival rates after 1 year were 62% and 57%, respectively. An analysis of risk factors was not possible due to the small number of cases. Conclusion: Orbital exenterations in conjunctival and uveal melanoma are rarely necessary, but can be performed as an ultima ratio treatment with curative intent. Disease-free survival and overall survival are significantly lower for both groups due to the advanced stage of the disease compared to patients treated without exenteration in the literature. If a recurrence occurs after exenteration, the prognosis is poor in both groups.


Sign in / Sign up

Export Citation Format

Share Document